Literature DB >> 21227593

Liver fluke isolates: a question of provenance.

I Fairweather1.   

Abstract

A survey of literature on experimental infections with the liver fluke, Fasciola hepatica published between 2005 and 2009 has revealed a general lack of information on where fluke material (i.e. metacercariae) was sourced from. Even less information was given on the drug status of the fluke isolate used, which is a particular concern for those studies that involved anthelmintics. In these two respects, information on the liver fluke lags far behind that for nematodes, where such information is given almost as a matter of course. Of additional concern is that, at times, information about the source and drug history of fluke isolates was incorrect. The overall aim of the review is to demonstrate why it is important to provide as much information as possible on what fluke material is being used. It also attempts to correct some of the errors in the literature and gather together what information is available about the provenance of those isolates that have been used in recent experimental studies.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21227593     DOI: 10.1016/j.vetpar.2010.12.011

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  14 in total

1.  Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica.

Authors:  C Devine; G P Brennan; C E Lanusse; L I Alvarez; A Trudgett; E Hoey; I Fairweather
Journal:  Parasitol Res       Date:  2011-03-26       Impact factor: 2.289

2.  Excretory/secretory products from two Fasciola hepatica isolates induce different transcriptional changes and IL-10 release in LPS-activated bovine "BOMA" macrophages.

Authors:  Piotr Bąska; Luke James Norbury; Anna Zawistowska-Deniziak; Marcin Wiśniewski; Kamil Januszkiewicz
Journal:  Parasitol Res       Date:  2017-08-19       Impact factor: 2.289

3.  Erratum to: inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica.

Authors:  C Devine; G P Brennan; C E Lanusse; L I Alvarez; A Trudgett; E Hoey; I Fairweather
Journal:  Parasitol Res       Date:  2011-08-14       Impact factor: 2.289

4.  Approach to molecular characterization of different strains of Fasciola hepatica using random amplified polymorphic DNA polymerase chain reaction.

Authors:  S Scarcella; E Miranda-Miranda; M V Solana; H Solana
Journal:  Parasitol Res       Date:  2015-01-18       Impact factor: 2.289

5.  Fasciola hepatica: time-dependent disruption of spermatogenesis following in vivo treatment with triclabendazole.

Authors:  Emma Toner; Gerard P Brennan; Robert E B Hanna; Hillary W J Edgar; Ian Fairweather
Journal:  Parasitol Res       Date:  2011-05-04       Impact factor: 2.289

6.  The Differences in the Susceptibility Patterns to Triclabendazole Sulfoxide in Field Isolates of Fasciola hepatica Are Associated with Geographic, Seasonal, and Morphometric Variations.

Authors:  Martha V Fernandez-Baca; Cristian Hoban; Rodrigo A Ore; Pedro Ortiz; Young-Jun Choi; César Murga-Moreno; Makedonka Mitreva; Miguel M Cabada
Journal:  Pathogens       Date:  2022-05-28

Review 7.  New approaches for understanding mechanisms of drug resistance in schistosomes.

Authors:  Robert M Greenberg
Journal:  Parasitology       Date:  2013-04-03       Impact factor: 3.234

Review 8.  Fasciola hepatica: Histology of the Reproductive Organs and Differential Effects of Triclabendazole on Drug-Sensitive and Drug-Resistant Fluke Isolates and on Flukes from Selected Field Cases.

Authors:  Robert Hanna
Journal:  Pathogens       Date:  2015-06-26

Review 9.  Recent advances in candidate-gene and whole-genome approaches to the discovery of anthelmintic resistance markers and the description of drug/receptor interactions.

Authors:  Andrew C Kotze; Peter W Hunt; Philip Skuce; Georg von Samson-Himmelstjerna; Richard J Martin; Heinz Sager; Jürgen Krücken; Jane Hodgkinson; Anne Lespine; Aaron R Jex; John S Gilleard; Robin N Beech; Adrian J Wolstenholme; Janina Demeler; Alan P Robertson; Claude L Charvet; Cedric Neveu; Ronald Kaminsky; Lucien Rufener; Melanie Alberich; Cecile Menez; Roger K Prichard
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-08-13       Impact factor: 4.077

10.  Fasciola hepatica demonstrates high levels of genetic diversity, a lack of population structure and high gene flow: possible implications for drug resistance.

Authors:  Nicola J Beesley; Diana J L Williams; Steve Paterson; Jane Hodgkinson
Journal:  Int J Parasitol       Date:  2016-12-07       Impact factor: 3.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.